1. Home
  2. SRPT vs CCK Comparison

SRPT vs CCK Comparison

Compare SRPT & CCK Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • SRPT
  • CCK
  • Stock Information
  • Founded
  • SRPT 1980
  • CCK 1906
  • Country
  • SRPT United States
  • CCK United States
  • Employees
  • SRPT N/A
  • CCK N/A
  • Industry
  • SRPT Biotechnology: Pharmaceutical Preparations
  • CCK Containers/Packaging
  • Sector
  • SRPT Health Care
  • CCK Industrials
  • Exchange
  • SRPT Nasdaq
  • CCK Nasdaq
  • Market Cap
  • SRPT N/A
  • CCK 10.4B
  • IPO Year
  • SRPT 1997
  • CCK N/A
  • Fundamental
  • Price
  • SRPT $36.52
  • CCK $97.33
  • Analyst Decision
  • SRPT Buy
  • CCK Strong Buy
  • Analyst Count
  • SRPT 23
  • CCK 12
  • Target Price
  • SRPT $131.09
  • CCK $108.83
  • AVG Volume (30 Days)
  • SRPT 3.8M
  • CCK 1.3M
  • Earning Date
  • SRPT 05-06-2025
  • CCK 04-28-2025
  • Dividend Yield
  • SRPT N/A
  • CCK 1.07%
  • EPS Growth
  • SRPT N/A
  • CCK 33.50
  • EPS
  • SRPT N/A
  • CCK 4.63
  • Revenue
  • SRPT $2,233,371,000.00
  • CCK $11,904,000,000.00
  • Revenue This Year
  • SRPT $64.51
  • CCK $2.43
  • Revenue Next Year
  • SRPT $22.40
  • CCK $2.48
  • P/E Ratio
  • SRPT N/A
  • CCK $21.03
  • Revenue Growth
  • SRPT 59.15
  • CCK 0.71
  • 52 Week Low
  • SRPT $35.46
  • CCK $70.84
  • 52 Week High
  • SRPT $173.25
  • CCK $98.48
  • Technical
  • Relative Strength Index (RSI)
  • SRPT 22.82
  • CCK 68.26
  • Support Level
  • SRPT $59.62
  • CCK $96.89
  • Resistance Level
  • SRPT $64.80
  • CCK $98.37
  • Average True Range (ATR)
  • SRPT 3.75
  • CCK 2.12
  • MACD
  • SRPT -1.21
  • CCK 0.91
  • Stochastic Oscillator
  • SRPT 3.61
  • CCK 92.46

About SRPT Sarepta Therapeutics Inc. (DE)

Sarepta Therapeutics Inc is a biotechnology company focused on treating rare, infectious, and other diseases. It targets a broad range of diseases while focusing on the rapid development of its drug candidates. Sarepta's involves proprietary RNA-targeted technology platforms to be used for developing novel pharmaceutical products to treat a broad range of diseases and address key unmet medical needs. The company uses third-party contractors to manufacture its product candidates. Majority of company's product candidates are at an early stage of development.

About CCK Crown Holdings Inc.

Crown Holdings is one of the world's largest producers of metal packaging. The company manufactures beverage cans, metal food cans, and closures as well as aerosol cans. With the purchase of Signode, the company also has a presence in a wide variety of protective transport packaging. Although it's headquartered in the United States, the vast majority of Crown's sales come from its operations in Europe, South America, and Southeast Asia.

Share on Social Networks: